We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$380M
AUM Growth
+$51.2M
Cap. Flow
+$18.7M
Cap. Flow %
4.92%
Top 10 Hldgs %
38.28%
Holding
210
New
18
Increased
73
Reduced
84
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.91M
2
ABT icon
Abbott
ABT
+$7.76M
3
BND icon
Vanguard Total Bond Market
BND
+$1.35M
4
OGN icon
Organon & Co
OGN
+$938K
5
V icon
Visa
V
+$610K

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 16.71%
3 Financials 10.29%
4 Industrials 9.17%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTIP icon
201
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$204K 0.05%
+3,975
New +$207K
LLY icon
202
Eli Lilly
LLY
$1.02T
$203K 0.05%
+735
New +$186K
PEO
203
Adams Natural Resources Fund
PEO
$739M
$203K 0.05%
12,791
+645
+5% +$10.4K
FLO icon
204
Flowers Foods
FLO
$1.5B
$202K 0.05%
7,360
-11,235
-60% -$290K
SF
205
Stifel
SF
$12.6B
$200K 0.05%
+4,271
New +$207K
ABEV icon
206
Ambev
ABEV
$47.9B
$92K 0.02%
32,880
+3,000
+10% +$8.6K
HELP
207
Cybin Inc
HELP
$491M
$12K ﹤0.01%
+263
New +$16.7K
BA icon
208
Boeing
BA
$169B
-919
Closed -$202K
DELL icon
209
Dell
DELL
$262B
-5,651
Closed -$298K
QVAL icon
210
Alpha Architect US Quantitative Value ETF
QVAL
$583M
-7,440
Closed -$254K

Similar funds

Roberts, Glore & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Roberts, Glore & Co held 210 positions worth $380M, up 16% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Roberts, Glore & Co deployed $18.7M of net new capital in Q4 2021, opening 18 new positions and adding to 73 existing holdings. Its largest new stake was Organon & Co: 28,791 shares worth $877K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cerner Corp, an estimated $1.16M trimmed.

  • Roberts, Glore & Co's largest Q4 2021 buy was Organon & Co: 28,791 shares worth $877K.
  • Roberts, Glore & Co added most to AbbVie in Q4 2021, an estimated $7.91M increase.
  • Roberts, Glore & Co's biggest Q4 2021 reduction was Cerner Corp, cutting an estimated $1.16M.
  • Roberts, Glore & Co fully exited Dell in Q4 2021, selling an estimated $298K.
  • Roberts, Glore & Co's ten largest holdings make up 38% of its $380M portfolio in Q4 2021.
  • Roberts, Glore & Co opened 18 new positions and closed 3 in Q4 2021.
  • Roberts, Glore & Co's portfolio value rose 16% quarter-over-quarter to $380M.

Based on Roberts, Glore & Co's 13F filing for Q4 2021, filed 11 Feb 2022.